Adverse effects of GLP-1 receptor agonists: difference between revisions
Diff·revision 7 → 8·15:16, 27 Aug 2024
Difference between revision 7 and revision 8 of Adverse effects of GLP-1 receptor agonists. 1 line changed; the page grew by 31 bytes.
| Revision 7 — 07:12, 13 Aug 2024 MergeMorwenna (talk) state that the frequency category follows the labelling convention 2,583 bytes +263 | Revision 8 — 15:16, 27 Aug 2024 LeanMassLars (talk) rm the reassurance sentence; the article should report, not reassure 2,614 bytes +31 | ||
|---|---|---|---|
| 32 | [[Category:Adverse effects]] | 32 | [[Category:Adverse effects]] |
| 33 | [[Category:Gastrointestinal adverse effects]] | 33 | [[Category:Gastrointestinal adverse effects]] |
| + | 34 | [[Category:Clinical practice]] | |
| 34 | 35 |